Sarepta Therapeutics
The Director, Translational Operations and Regulatory Integration leads the operational strategy and regulatory readiness for Sarepta's Translational Biology portfolio across gene therapy and genetic medicine programs. This leadership role ensures cross-functional alignment and execution of biomarker and translational plans while managing risks and driving scalable operational processes. The position serves as a strategic connector across research, clinical development, and regulatory affairs to support successful health authority submissions and post-marketing commitments.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sarepta Therapeutics.
Sarepta Therapeutics CEO Doug Ingram will retire after a tumultuous decade
2 weeks ago
Vice President, Translational Medicine
Annexon Biosciences
Director, Oncology Early Translational Biomarkers
GSK plc
Senior Director, Clinical Translational Scientist
Kiniksa Pharmaceuticals
Translational Medicine Director
Isomorphic Labs
Senior Director, Biomarker Development, Strategy, and Operations
Zenas BioPharma
Senior Principal Scientist, Cardiovascular, Translational Development
Bristol Myers Squibb